Paper Details
- Home
- Paper Details
The effects of low-dose Bay-m-1099 (Miglitol) on serum lipids and liver enzyme activity of obese and obese-diabetic corpulent rats.
Author: DeBounoJ F, MichaelisO E, SzepesiB, TulpO L
Original Abstract of the Article :
1. Groups of lean, obese, and obese-non-insulin-dependent diabetic LA/N-cp and SHR/N-cp rats were administered the a-glucosidase inhibitor Miglitol (150 mg/kg diet, ad libitum) from 8 until 15 weeks of age. 2. Phenotype effects (obese greater than lean) were present for weight gain, adiposity, serum...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/0742-8413(91)90105-3
データ提供:米国国立医学図書館(NLM)
The Effects of Miglitol on Obese Rats
In the vast and ever-expanding desert of metabolic research, scientists are constantly seeking new oases of knowledge to quench our thirst for understanding how our bodies function. This study, like a camel traversing a scorching landscape, delved into the effects of low-dose Miglitol on obese rats. The researchers used a-glucosidase inhibitor Miglitol (150 mg/kg diet) to investigate its impact on various metabolic parameters, including weight gain, adiposity, serum glycemic and lipid profiles, and liver enzyme activity. They discovered that Miglitol treatment was associated with improvements in glucokinase and malic enzyme in both lean and obese rats, and in improvements in glycemic parameters in obese rats.
Promising Results for Glucose Control
The researchers found that Miglitol treatment led to significant improvements in glucose control and insulin action. This suggests that Miglitol could potentially be used to manage diabetes in obese individuals. The study suggests that Miglitol might exert its effects through indirect mechanisms, potentially influencing insulin sensitivity in peripheral tissues and modulating the activity of glucoregulatory enzymes.
Miglitol: A Potential Tool for Managing Obesity and Diabetes
This study offers hope for a potential treatment for obesity and diabetes. While Miglitol showed positive results in improving glucose control, it may require higher dosages or longer treatment durations to achieve comparable improvements in adiposity or plasma lipid profiles. This study emphasizes the importance of further research to optimize Miglitol treatment for maximum benefit in the fight against metabolic diseases.
Dr.Camel's Conclusion
This study is like a refreshing oasis in the desert of metabolic research, providing valuable insights into the potential of Miglitol for managing obesity and diabetes. While further research is needed, these findings are promising and offer hope for a better future for those struggling with these conditions.
Date :
- Date Completed 1991-08-01
- Date Revised 2020-08-25
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.